Jane Street Group, LLC Entera Bio Ltd. Transaction History
Jane Street Group, LLC
- $616 Billion
- Q3 2025
A detailed history of Jane Street Group, LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Jane Street Group, LLC holds 30,528 shares of ENTX stock, worth $82,730. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,528
Previous 10,187
199.68%
Holding current value
$82,730
Previous $19,000
205.26%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ENTX
# of Institutions
25Shares Held
9.21MCall Options Held
21.1KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$15.9 Million6.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.18MShares$3.19 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0627KShares$1.7 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY567KShares$1.54 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT281KShares$761,0270.07% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $78.1M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...